KALO — Kallo Income Statement
0.000.00%
Last trade - 00:00HealthcareHighly SpeculativeMicro Cap
Annual income statement for Kallo, fiscal year end - December 31st, USD millions except per share, conversion factor applied.
2017 December 31st | 2018 December 31st | 2019 December 31st | 2020 December 31st | 2021 December 31st | |
|---|---|---|---|---|---|
| Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
| Source: | 10-K | 10-K | 10-K | 10-K | 10-K |
| Standards: | USG | USG | USG | USG | USG |
| Status: | Final | Final | Final | Final | Final |
| Total Revenue | 0 | 0 | 0 | 0 | 0 |
| Selling / General / Administrative Expenses | |||||
| Depreciation and Amortization | |||||
| Unusual Expense / Income | |||||
| Total Operating Expenses | 7.03 | 0.764 | 2.36 | 36.1 | 8.09 |
| Operating Profit | -7.03 | -0.764 | -2.36 | -36.1 | -8.09 |
| Net Income Before Taxes | -7.03 | -0.764 | -2.36 | -36.1 | -8.09 |
| Net Income After Taxes | -7.03 | -0.764 | -2.36 | -36.1 | -8.09 |
| Net Income Before Extraordinary Items | |||||
| Net Income | -7.03 | -0.764 | -2.36 | -36.1 | -8.09 |
| Income Available to Common Shareholders Excluding Extraordinary Items | |||||
| Income Available to Common Shareholders Including Extraordinary Items | |||||
| Diluted Net Income | -7.03 | -0.764 | -2.36 | -36.1 | -8.09 |
| Diluted Weighted Average Shares | |||||
| Basic EPS Including Extraordinary Items | |||||
| Diluted EPS Including Extraordinary Items | |||||
| Diluted EPS Excluding Extraordinary Items | |||||
| Normalised Income Before Taxes | |||||
| Normalised Income After Taxes | |||||
| Normalised Income Available to Common Shareholders | |||||
| Diluted Normalised EPS | -0.01 | -0.001 | -0.002 | -0.031 | -0.004 |